Asset Management One
LEGN icon

Asset Management One’s Legend Biotech LEGN Stock Holding History

Asset Management One’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Hold
10,575
– – ﹤0.01% 866
2026
Q1 		$191K Hold
10,575
– – ﹤0.01% 861
2025
Q4 		$232K Hold
10,575
– – ﹤0.01% 866
2025
Q3 		$345K Hold
10,575
– – ﹤0.01% 832
2025
Q2 		$375K Sell
10,575
-510
-5% -$16.5K ﹤0.01% 818
2025
Q1 		$376K Hold
11,085
– – ﹤0.01% 830
2024
Q4 		$360K Buy
11,085
+2,297
+26% +$95.1K ﹤0.01% 852
2024
Q3 		$428K Hold
8,788
– – ﹤0.01% 848
2024
Q2 		$389K Sell
8,788
-600
-6% -$27.7K ﹤0.01% 844
2024
Q1 		$527K Buy
9,388
+333
+4% +$20.1K ﹤0.01% 850
2023
Q4 		$542K Buy
9,055
+526
+6% +$33.3K ﹤0.01% 845
2023
Q3 		$573K Sell
8,529
-867
-9% -$60.2K ﹤0.01% 856
2023
Q2 		$649K Buy
9,396
+1,326
+16% +$86.6K ﹤0.01% 861
2023
Q1 		$389K Buy
8,070
+247
+3% +$12.1K ﹤0.01% 891
2022
Q4 		$389K Sell
7,823
-1,994
-20% -$96.6K ﹤0.01% 890
2022
Q3 		$400K Buy
9,817
+2,849
+41% +$134K ﹤0.01% 894
2022
Q2 		$383K Sell
6,968
-11,262
-62% -$476K ﹤0.01% 909
2022
Q1 		$662K Hold
18,230
– – ﹤0.01% 876
2021
Q4 		$861K Buy
+18,230
New +$925K ﹤0.01% 876

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Asset Management One's LEGN Position: Q2 2026 in Review

Asset Management One held its Legend Biotech (LEGN) position steady in Q2 2026 at 10,575 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Asset Management One first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $861K in Q4 2021. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Asset Management One held 10,575 shares of Legend Biotech worth $305K as of Q2 2026.
  • Asset Management One left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Asset Management One's portfolio in Q2 2026, its #866 holding.
  • Asset Management One first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Asset Management One's Legend Biotech position peaked at $861K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.